You just read:

T-Cell Redirecting Bispecific Antibodies 2016: Despite Stunning Clinical Results with CD19-targeted CAR T-cells, Many Major Pharmaceutical Companies Have not Embarked on This Field of Adoptive Cell Therapy - Research and Markets

News provided by

Research and Markets

May 27, 2016, 14:10 ET